Stock Option holder to be wipe out
I am not inventing this fact. It's in the Sedar report.
I am confident in GBM results.
It's the ninth month of testing and in one week the tenth month.
Concordia Pharm provided solid anti-tumor activities with a less potent drug.
4601 is custom design for GBM - Decipher tech was about prometic iteration.
232 has entered arbitration. After that we get a settlement, I think TLN will win the settlement. Worst case, it will just give a bigger portion of the pie to AsperGen.. Again in the Sedar document.
With resolution of 232, we will finally get full valuation for this awesome compound.
Thallion does not have any going concern, so Shigamabs partnership is for real. Potential partners don't want to enter into an agreement with a cash strap partner. Not the case anymore.
Tax conversion deal was fair and honest. This is truly an unforseen lucky event. We got it. Other biotech did not get such a deal.
Either bullish or bearish on a stock. At one point it is undervalued. I think this stock sits on good valuation.
1/4 cash value.
I am happy with today's trading. Bid/Ask picture was terrible and we still manage a gain. Stock is oversold now.
I will be adding more...
Big news of the days is option holder wipe out. Option holders have until the arrangement to exercise their options, if so we get even more anti-dilutive cash, because all options are trade in at much higher price.
I don't think all of management and all of employees sacrificed their future gains for no reason.
If there is a deal, tax conversion can still be possible (see clause 3.4) and option holders will have a net gain on conversion.
This deal is absolutely non dilutive for new shareholders.
I expect people zooming in and buying those weak hands.